20-12-2025, 03:10

U.S. FDA approves JASCAYD® (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults

Notified -
Globe Newswire20-12-2025, 03:10
10-12-2025, 17:35

JASCAYD® (nerandomilast) receives first regulatory approval for progressive pulmonary fibrosis in China

Notified -
Globe Newswire10-12-2025, 17:35